Early-phase drug discovery of ß-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5.
J Biol Chem
; 299(3): 102956, 2023 03.
Article
in En
| MEDLINE
| ID: mdl-36731793
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Actins
/
Spectrin
/
Spinocerebellar Ataxias
Limits:
Humans
Language:
En
Journal:
J Biol Chem
Year:
2023
Type:
Article
Affiliation country:
United States